Back to Stakeholders

The First Affiliated Hospital of Chongqing Medical University is a major academic teaching hospital in Chongqing, China, that has been a prolific clinical site for ketamine and esketamine research, with multiple randomized controlled trials spanning postpartum depression prevention, major depressive disorder combined with electroconvulsive therapy, and depression following miscarriage. Its departments of psychiatry and anesthesiology have published landmark studies demonstrating esketamine's efficacy across multiple psychiatric indications.

Academic Research

0 papers

Published Papers

0

Trial Involvement

4

Distinct Focus Topics

0

Latest Publication

Unknown

Clinical Care Delivery Snapshot

Health Systems & Hospitals

Provider Model

Health System / Hospital Program

Organization Status

Unknown

Psychedelic Services

Unknown

Service Coverage

Global

Service Profile

Care Settings

Hospital Outpatient

Payer Models

Unknown

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Backfilled profile for existing L2 clinical care delivery stakeholder.

Quick Facts

Type
Other
HQ
China
Website
Visit

Sponsored Trials

4